Evidence map›Paper›PMID 27089939›Full record

ArticleImmunology and cell biology2016

Overexpression of Vα14Jα18 TCR promotes development of iNKT cells in the absence of miR-181a/b-1.

Jonas Blume, Susanne Zur Lage, Katrin Witzlau, Hristo Georgiev, Siegfried Weiss, Marcin Łyszkiewicz, Natalia Ziȩtara, Andreas Krueger

Abstract read
PubMed Publisher
In one paragraph

Article in Immunology and cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. microRNA dynamic expression regulates invariant NKT cells.Cellular and molecular life sciences : CMLS · 2021
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jonas BlumeInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Susanne Zur LageMolecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Katrin WitzlauInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Hristo GeorgievInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Siegfried WeissInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Marcin ŁyszkiewiczInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Natalia ZiȩtaraInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Andreas KruegerInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DEHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expression of microRNA miR-181a/b-1 is critical for intrathymic development of invariant natural killer T (iNKT) cells. However, the underlying mechanism has remained a matter of debate. On the one hand, growing evidence suggested that miR-181a/b-1 is instrumental in setting T-cell receptor (TCR) signaling threshold and thus permits agonist selection of iNKT cells through high-affinity TCR ligands. On the other hand, alterations in metabolic fitness mediated by miR-181a/b-1-dependent dysregulation of phosphatase and tensin homolog (Pten) have been proposed to cause the iNKT-cell defect in miR-181-a/b-1-deficient mice. To re-assess the hypothesis that modulation of TCR signal strength is the key mechanism by which miR-181a/b-1 controls the development of iNKT cells, we generated miR-181a/b-1-deficient mice expressing elevated levels of a Vα14Jα18 TCRα chain. In these mice, development of iNKT cells was fully restored. Furthermore, both subset distribution of iNKT cells as well as TCR Vβ repertoire were independent of the presence of miR-181a/b-1 once a Vα14Jα18 TCRα chain was overexpressed. Finally, levels of Pten protein were similar in Vα14Jα18 transgenic mice irrespective of their miR-181a/b-1 status. Collectively, our data support a model in which miR-181 promotes development of iNKT cells primarily by generating a permissive state for agonist selection with alterations in metabolic fitness possibly constituting a secondary effect.

Indexed as

AnimalsCell PolarityLymphocyte SubsetsMice, TransgenicMicroRNAsNatural Killer T-CellsPTEN PhosphohydrolaseReceptors, Antigen, T-Cell, alpha-betaTransgenesMicroRNAsmirn181 microRNA, mousePTEN PhosphohydrolaseReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID27089939
OpenAlexW2342145261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.